Cramer Remix: AbbVie and Biogen are the best-in-show biotechs for 2018 so far
January 31, 2018 at 19:00 PM EST
Jim Cramer breaks down his take on the biotech pullback and which two he thinks could be top performers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|